Thursday’s trading session is witnessing notable fluctuations among stocks across the board, with significant movements in both the mega-cap and large-cap categories. Oracle Corp (NYSE:ORCL) and Dell Inc (NYSE:DELL) are among the stocks experiencing declines, while MicroStrategy Inc (NASDAQ:MSTR) is surging. Here’s a look at some of the key stock movers today, spanning from mega-caps to small caps.
Mega-Cap Movers (Market Cap $200B+):
Oracle Corp (ORCL): -4.03%
Salesforce Com (NYSE:CRM): -3.84%
Avago Technologies (NASDAQ:AVGO): -3.08%
Servicenow Inc (NYSE:NOW): -2.68%
Adobe Sys Inc (NASDAQ:ADBE): -2.21%
Large-Cap Stock Movers (Market Cap $10B-$200B):
Dell Inc (DELL): -12.25%
Hewlett-pack (NYSE:HPQ): HP stock downgraded to Hold by HSBC on weak 1QFY25 outlook and rising commodity costs; -11.36%
MicroStrategy Inc (MSTR): +9.94%
Autodesk Inc (NASDAQ:ADSK): -8.59%
Nutanix Inc (NASDAQ:NTNX): Nutanix to Present at Upcoming Investor Conference; -7.81%
BeiGene (NASDAQ:BGNE): +7.31%
Reinvent Technology Partners Y (AUR): +7.27%
Li Auto Inc (NASDAQ:LI): American Lithium Reports Results of Annual General and Special Meeting; +6.78%
IBIT NASDAQ (IBIT): +6.44%
FBTC NYSE (FBTC): +6.37%
Mid-Cap Stock Movers (Market Cap $2B-$10B):
SVF Investment 3 (SYM): -35.87%
Iris Energy (IREN): +29.71%
Arrowhead Research Corp (NASDAQ:ARWR): +24.23%
Urban outfitters (NASDAQ:URBN): +18.31%
Hut 8 Mining PK (HUT): +16.5%
HCM Acquisition (MRNO): +16.17%
Good Works Acquisition (CIFR): +14.56%
MSTU (MSTU): +13.93%
Small-Cap Stock Movers (Market Cap $300M-$2B):
Advanced Photonix Inc (API): +33.97%
ETHU (ETHU): +18.79%
Golden Bull (BTBT): +18.45%
Fate Therap (NASDAQ:FATE): +18.28%
Kingsoft Cloud Holdings Ltd (KC): +17.42%
Immunome Inc (NASDAQ:IMNM): +16.83%
Wowo Ltd (MFH): -16.32%
Semler Scientifc (NASDAQ:SMLR): +16.06%
Applied Therapeutics Inc (NASDAQ:APLT): FDA declines approval for Applied Therapeutics’ Galactosemia drug; -16.06%
For real-time, market-moving news, join Investing Pro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.